NCT02194075View on ClinicalTrials.gov

Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Obsessive Compulsive Disorder
Interventions
DRUG

Fluvoxamine+Methylphenidate hydrochloride

DRUG

Fluvoxamine+sugar pill

Trial Locations (1)

510180

Guangdong General Hospital, Guangdong academy of medical science, Guangzhou

All Listed Sponsors
lead

Guangdong Provincial People's Hospital

OTHER

NCT02194075 - Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive Disorder | Biotech Hunter | Biotech Hunter